Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury

Journal of Clinical Investigation

Volumn 104, Issue 11, 1999, Pages 1631-1639

  Amersi, Farin ^a   Buelow, Roland ^b   Kato, Hirohisa ^a   Ke, Bibo ^a   Coito, Ana J ^a   Shen, Xiu Da ^a   Zhao, Delai ^a   Zaky, Joseph ^a   Melinek, Judy ^c   Lassman, Charles R ^c   Kolls, Jay K ^d   Alam, J ^e   Ritter, Thomas ^f   Volk, Hans Dieter ^f   Farmer, Douglas G ^a   Ghobrial, Rafik M ^a   Busuttil, Ronald W ^a   Kupiec Weglinski, Jerzy W ^a  

^a UCLA MEDICAL CENTER   (United States)

^b GENZYME CORPORATION   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e OCHSNER MEDICAL CENTER   (United States)

^f HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEME OXYGENASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; HISTOPATHOLOGY; LIVER FUNCTION; LIVER ISCHEMIA; LIVER TRANSPLANTATION; NONHUMAN; OBESITY; PORTAL VEIN BLOOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

EID: 0033452790     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7903     Document Type: Article

References (51)

1. Markin, R.S., et al. 1993. Frozen section evaluation of donor livers before transplantation. Transplantation. 56:1403-1409.
2. Hornboll, P., and Olsen, T.S. 1982. Fatty changes in the liver: the relation to age, overweight, and diabetes mellitus. Acta Path. Microbiol. Immunol. Scand. /A./ 90:199-205.
3. D'Allessandro, A.M., Kalayoglu, M., and Sollinger, H.W. 1991. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation. 51:157-162.
4. Strasberg, S.M., Howard, J.K., Melmenti, E.P., and Hersh, M. 1994. Selectnig the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology. 20:829-838.
5. Fellstrom, B., Akuyrek, L.M., and Zezina, L. 1998. Post ischemic reperfusion injury and allograft arteriosclerosis. Transplant. Proc. 38:4278-4280.
6. Dulkanchainun, T.S., et al. 1998. Reduction of hepatic ischemia/reperfusion injury by a soluble p-selectin glycoprotein ligand-1. Ann. Surg. 227:832-840.
7. Thurman, R.G., et al. 1988. Hepatic reperfusion injury following orthotopic liver transplantation in the rat. Transplantation. 46:502-506.
8. Serizawa, A., Nakamure, S., Suzuki, S., Baba, S., and Nakano, M. 1996. Involvement of platelet activating factor in cytokine production and neutrophil activation after hepatic ischemia reperfusion. Hepatology. 23:1656-1663.
9. Goode, H.F., et al. 1994. Reperfusion injury, antioxidants and hemodynamics during OLT. Hepatology. 19:354-360.
10. Shau, H., and Kim, A. 1994. Identification of natural killer enhancing factor as a major antioxidant in human red blood cells. Biochem. Biophys. Res. Commun. 199:83-87.
11. Manies, M.D. 1992. Heme oxygenase: clinical applications and functions. CRC Press, Boca Raton, FL. 276 pp.
12. Rodgers, P.A., Seidman, P.S., Wei, P.L., Denney, P-A., and Stevenson, D.C. 1996. Duration of action and tissue distribution of zinc protoporphyrin in neonatal rats. Pediatr. Res. 39:1041-1049.
13. Soares, M.P., et al. 1998. Expression of HO-1 can determine cardiac xenograft survival. Nat. Med. 4:1073-1077.
14. Woo, J., et al. 1998. Stress protein-induced immunosuppression: inhibition of cellular immune effector functions following overexpression of haem oxygenase (HSP 32). Transpl. Immunol. 6:84-93.
15. Hancock, W.W., Buelow, R., Sayegh, M.H., and Turka, L.A. 1998. Antibody induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat. Med. 12:1392-1396.
16. Panahian, N., Yoshiura, M., and Manies, M.D. 1999. Overexpression of heme oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice. J. Neurochem. 72:1187-1203.
17. Shibahara, S., Muller, R., Taguchi, H., and Yoshida, T. 1985. Cloning and expression of cDNA for rat heme oxygenase. Proc. Natl. Acad. Sci. USA. 93:10393-10398.
18. Graham, F.L., and Prevec, L. 1992. Manipulation of adenoviral vectors in molecular biology. Gene transfer and expression protocols. Biotechnology. 20:363-390.
19. Gomez-Foix, A.M., et al. 1992. Adenovirus mediated gene transfer of the muscle glycogen phosphorylase gene into hepatocyte confers altered regulation of glycogen metabolism. J. Biol. Chem. 267:25129-25134.
20. Fallaux, F.J., et al. 1996. Characterization of 911: a new helper cell line for the titration and propagation of early region I-deleted adenoviral vectors. Hum. Gene Ther. 7:215-222.
21. McGrory, W.J., Bautista, D.S., and Graham, F.L. 1988. A simple technique for the rescue of early region 1 mutations into infectious human adenovirus type 5. Virology. 163:614-617.
22. Kolls, J., Peppel, K., Silva, M., and Beutler, B. 1994. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA. 91:215-219.
23. Kamada, N., and Calne, R.Y. 1979. Orthotopic liver transplantation in the rat technique using cuff for portal vein anastomosis and biliary drainage. Transplantation. 28:47-48.
24. Demetris, A.J., et al., International Banff Schema Consensus Conference. The Third Banff Conference on Allograft Pathology. June 21 25, 1995. Banff, Alberta, Canada.
25. Suzuki, S., Toledo-Pereyra, L.H., Rodriguez, F.J., and Cejalvo, D. 1993. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Transplantation. 55:1265-1272.
26. Coito, A.J., Binder, J., de Sousa, M., and Kupiec-Weglinski, J.W. 1994. The expression of extracellular matrix proteins during accelerated rejection of cardiac allografts in sensitized rats. Transplantation. 57:599-605.
27. Coito, A.J., et al. 1995 Anti-TNF-α antibody treatment downregulates the expression of fibronectin and decreases cellular infiltration of cardiac allografts in rats. J. Immunol. 154:2949-2958.
28. Ignarro, L.J., Ballot, B., and Woods, K.S. 1984 Regulation of soluble guanylate cyclase activity by porphyrins and metalloporphyrins. J. Biol. Chem. 259:6201-6207.
29. Wolff, D., Naddelman, R.A., Lubeskie, A., and Sulcs, D.A. 1996. Inhibition of nitric oxide synthase isoforms by porphyrins. Arch. Biochem. Biophys. 333:27-34.
30. Otterbein, L.E., et al. 1999. Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia induced lung injury. J. Clin. Invest. 103:1047-1054.
31. Taneja, C., Prescott, L., and Koneru, B. 1998. Critical preservation injury in rat fatty livers is to hepatocytes, not sinusoidal lining cells. Transplantation. 65:167-172.
32. Gonzales-Flecha, B., Cutrin, J.C. and Bovens, A. 1993. Time course and mechanism of oxidative stress and tissue damage in rat liver subjected to ischemia reperfusion. J. Clin. Invest. 91:456-460.
33. Iyer, J., et al. 1998. Characterization and biological significance of immunosuppressive peptide D2702.75-84 (E-V) binding protein. J. Biol. Chem. 273:2692-2697.
34. Nath, K.A., et al. 1994. The functional significance of the induction of heme oxygenase by oxidative stress. J. Lab. Clin. Med. 123:461-463.
35. Nath, K.A., et al. 1992. Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J. Clin Invest. 90:267-270.
36. Parry, N., Buelow, R., Jiang, J., Garcia, B., and Zhong, R. 1999. A rationally designed immunomodulatory peptide upregulates expression of hemoxygenase-1 and attenuates chronic rejection in a rat renal allograft model. Transplantation. 67:S252.
37. Laniado-Schwartzman, M., et al. 1996. Heme oxygenase induction with attenuation of experimentally induced corneal inflammation. Biochem. Pharmacol. 53:1069-1073.
38. Willis, D., Moore, A.R., Frederick, R., and Willoughby, D.A. 1996. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat. Med. 2:87-90.
39. Squiers, E.C., Bruch, D., Buelow, R., and Tice, D.G. 1999. Pretreatment of small bowel isograft donors with cobalt-protoporphyrin decreases preservation injury. Transplant. Proc. 31:585-589.
40. Lee, P.J., Alam, J., Wiegand, G.W., and Choi, A.M.K. 1996. Overexpression of hemoxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia. Proc. Natl. Acad. Sci. USA. 93:10393-10399.
41. Vogt, B.A., et al. 1996, Glomerular inflammation induces resistance to tubular injury in the rat. J. Clin. Invest. 98:2139-2145.
42. Agarwal, A., Balla, J., Alam, J., Croatt, J., and Math, K.A. 1995. Induction of heme oxygenase (HO) in renal injury: a protective role in acute cisplatin nephrotoxicity in the rat. Kidney Int. 48:1298-1307.
43. Otterbein, L., Sylvester, S.L., and Choi, A.M.K. 1995. Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme exygenase-1. Am. J. Respir. Cell Mol. Biol. 13:595-602.
44. Poss, K.D., and Tonegawa, S. 1997. Reduced stress defense in heme oxygenate 1 deficient cells. Proc. Natl. Acad. Sci. USA. 9:10925-10930.
45. Yachie, A., et al. 1999. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest. 103:129-135.
46. Nagakami, T., Toyomura, K., Kinoshita, T., and Morisawa, S. 1993. A beneficial role of bile pigments as an endogenous tissue protector: Anticomplement effects of biliverdin and conjugated bilirubin. Biochem. Biophys. Acta. 1158:189-193.
47. Haga, Y., Temepero, A.M., Kay, D., and Zetterman, R.K. 1996. Intracellular accumulation of unconjugated bilirubin inhibits phytohemagglutinin-induced proliferation and interleukin-2 production of human lymphocytes. Dig. Dis. Sci. 41:1468-1474.
48. Haga, Y., Tempero, M.A., and Zetterman, R.K. 1996. Unconjugated bilirubin inhibits in vitro major histocompatibility complex-unrestricted cytotoxicity in human lymphocytes. Biochem. Biophys. Acta. 1316:29-34.
49. Maines, M.D. 1997. The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37:517-554.
50. Brune, B., and Ulrich, V. 1987. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol. Pharmacol. 32:497-504.
51. Neuzil, J., and Stocker, R. 1994. Free and albumin-bound bilirubin are efficient antioxidants for α-tocopherol, inhibiting plasma and low-density lipoprotein poroxidation. J. Biol. Chem. 269:16712-16719.